Delivery Order SPE2DB20D1004-SPE2DB25FNHVD
- Not listed
- The Defense Logistics Agency awarded a $3,071.37 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This firm fixed-price contract, which is scheduled for completion by August 20, 2025, represents a routine pharmaceutical procurement supporting military healthcare operations. The award was made on a competitive basis without any set-aside designation, and performance will be executed from the contractor's facility...
- The Defense Logistics Agency awarded a delivery order valued at $3,737.07 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 unit/mL 3mL insulin pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at approximately $74,717 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes a firm fixed price structure and carries no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $1,384.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This is a non-set-aside contract with an ultimate completion date of August 13, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $67,932.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 unit/ml 3ml insulin pens, with an ultimate completion date of July 15, 2025. This non-set-aside competitive award was issued on July 14, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Tresiba is a long-acting basal insulin used in diabetes management, reflecting the agency's ongoing procurement of...
- The Defense Logistics Agency awarded a $4,152.30 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $2,491.38 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/mL 3mL insulin pens on May 6, 2025, with completion scheduled for May 7, 2025. This competitively awarded, firm fixed-price contract represents a small-value pharmaceutical procurement with no set-aside designation. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $1,384.20 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL 3mL insulin pens on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,907.21 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This firm fixed price, non-competitive delivery order was issued on July 7, 2025, with an ultimate completion date of July 8, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The product is a branded insulin medication used for diabetes management within the military and federal...
- The Defense Logistics Agency awarded a $1,424.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Tresiba FlexTouch 200 Unit/mL 3mL insulin pens. This is a non-set-aside competitive award with an ultimate completion date of July 14, 2025, and performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNHVDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,033.64 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. This competitively awarded, firm fixed-price delivery order was issued on June 17, 2025, with an ultimate completion date of June 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's qualification to compete in open federal procurement processes. This delivery order represents a task placed against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen serves as a prime pharmaceutical vendor for federal military and veteran healthcare systems, supplying an extensive portfolio of medications, vaccines, and medical supplies globally. The Tresiba insulin product delivery supports the Defense Health Agency and other government healthcare customers requiring diabetes management pharmaceuticals as part of the broader federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 6/17/25 |